Signal Boost: Real-World Evidence Fits US FDA’s Safety Ambitions More Easily Than Efficacy

 
• By Bridget Silverman
  
Using real-world evidence requires identification of signals in a universe of noisy data. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Real-World Evidence

More from Pathways & Standards